BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  BD Reports First Quarter Fiscal 2024 Financial Results

  BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal 2024, which ended December 31, 2023.

  February 1, 2024

   · 

  28 min read
• Business

  Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results

  Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2023.

  February 1, 2024

   · 

  39 min read
• Pharm Country

  ITM Obtains Manufacturing License in the U.S.

  ITM Isotope Technologies Munich SE announced that the company has obtained a wholesale license issued by the New Jersey Department of Health in order to operate as a virtual manufacturer.

  February 1, 2024

   · 

  3 min read
• Business

  Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook

  Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook.

  February 1, 2024

   · 

  35 min read
• Pharm Country

  Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

  Century Therapeutics today announced that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Tuesday, February 8th, 2024 at 2:30 PM ET.

  February 1, 2024

   · 

  5 min read
• Biotech Bay

  IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

  IGM Biosciences, Inc. today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 2:30 p.m. EST in New York.

  February 1, 2024

   · 

  1 min read
• Pharm Country

  Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024

  Amicus Therapeutics (Nasdaq: FOLD), today announced that one oral presentation and 11 posters across its development programs will be included at the 20th Annual WORLDSymposium™ 2024, being held February 4-9, 2024 in San Diego, CA.

  February 1, 2024

   · 

  5 min read
• Business

  Labcorp Named One of the World’s Most Admired Companies™ by FORTUNE® Magazine

  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to FORTUNE® magazine’s list of the World’s Most Admired Companies™, a recognition of the most respected and reputable companies globally.

  February 1, 2024

   · 

  1 min read
• Business

  Remix Therapeutics Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer

  Remix Therapeutics today announced the appointment of Dominic Reynolds, Ph.D., as Chief Scientific Officer (CSO).

  February 1, 2024

   · 

  2 min read
• Antibe Extends Early Warrant Exercise Incentive Program

  Antibe Therapeutics Inc. is extending the Early Warrant Exercise Incentive Program for its 6.4 million outstanding and unlisted share purchase warrants having an exercise price of $1.50 and expiring on July 31, 2024.

  February 1, 2024

   · 

  3 min read